4 Results for "

CDK9-IN-8

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CDK9-IN-8" in MCE Product Catalog:

Cat. No.: HY-102039
CAS No.: 2105956-51-0
Purity:  99.65%
Target:  

CDK

Research Areas:  

Cancer

CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC50 of 12 nM.
loading...
    loading...
Cat. No.: HY-102039R
CAS No.: 2105956-51-0
Target:  

Reference Standards CDK

Research Areas:  

Cancer

CDK9-IN-8 (Standard) is the analytical standard of CDK9-IN-8 (HY-102039). This product is intended for research and analytical applications. CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC50 of 12 nM.
loading...
    loading...
Cat. No.: HY-149870
CAS No.: 2994191-89-6
Target:  

PROTACs CDK

Research Areas:  

Cancer

PROTAC CDK9 degrader-8 (compound 21) is a potent PROTAC CDK9 degrader with an IC50 value of 0.01 μM. PROTAC CDK9 degrader-8 can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-180124
Research Areas:  

Cancer

CDK8-IN-20 (Compound 67j) is a selective, potent and orally active type I CDK8 inhibitor with an IC50 of 70.5 nM. CDK8-IN-20 shows IC50 values of 147.8, 726.9 and 217.4 nM for homologous kinase CDK19, CDK7 and CDK9. CDK8-IN-20 can inhibit the Wnt/β-catenin pathway and downregulate the expression of β-catenin, Cyclin D1, and c-Myc. CDK8-IN-20 can induce ROS production and cause G2/M and S phase arrest. CDK8-IN-20can be used for the research of cancer, such as colon cancer .
loading...
    loading...